Status:
COMPLETED
Prophylactic Laser Treatment of Drusen Maculopathy
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
To study the effect of mild laser treatment on the incidence of exudative complications in soft drusen maculopathy. We hypothesise that mild laser treatment causing a proliferation of the retinal pigm...
Eligibility Criteria
Inclusion
- \> 55 years of age,
- Soft drusen maculopathy,
- VA 0.8-1.0
Exclusion
- VA \<0.8,
- Pigment clumps,
- PED,
- CNV,
- Atrophy,
- Haemorrhage,
- Diabetes retinopathy,
- Sign cataract,
- Glaucoma
Key Trial Info
Start Date :
December 1 1999
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00348543
Start Date
December 1 1999
End Date
October 1 2006
Last Update
August 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Ophthalmology, Linköping University
Linköping, Sweden, SE-581 85